The Effectiveness of BreatheMAX Breathing Device on Secretion Clearance

NCT ID: NCT01090804

Last Updated: 2010-03-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2/PHASE3

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determined effects of BreatheMAX on secretion clearance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

breathing exercise

BreatheMAX breathing device is Water pressure Threshold Bottle. The level of water in the cylinder determines the load for treatment. In the treatment using 20% PNIP (Peak negative inspiratory pressure) was performed with 6-10 breaths/set; 10 set/day

Group Type EXPERIMENTAL

BreatheMAX breathing device

Intervention Type DEVICE

secretion clearance, breathing exercise

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BreatheMAX breathing device

secretion clearance, breathing exercise

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* One sign of secretion accumulation in bronchi
* Stable cardiopulmonary function
* Good consciousness and good co-operation

Exclusion Criteria

* Massive hemoptysis
* Pneumothorax (untreated)
Minimum Eligible Age

15 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Khon Kaen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Khon Kaen University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sujittra Kluayhomthong, Bachelor

Role: STUDY_CHAIR

Physical Therapy department, Faculty of Associated Medical Sciences, Khon Kaen university

Chulee CU Jones, Philosophy

Role: STUDY_DIRECTOR

Physical Therapy Department, Faculty of Associated Medical Sciences, Khon Kaen university, Thailand

Wilaiwan Khrisanapant, Philosophy

Role: STUDY_DIRECTOR

Department of physiology, Faculty of medicine, Khon Kaen university

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pulmonary research room of physical therapy department, Faculty of associated medical sciences, Khon Kaen University

Muang, Changwat Khon Kaen, Thailand

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Miss Sujittra Kluayhomthong, Bachelor

Role: CONTACT

081-379-0647

Mrs. Chulee Jones, Philosophy

Role: CONTACT

664-320-2399

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sujittra Kluayhomthong, Bachelor

Role: primary

668-139-0647

Chulee CU Jones, Philosophy

Role: backup

664-320-2399

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

47660279

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.